CLINICAL_TRIALS
trial_result
· 2011-05-17
Clinical Trial Update: CONCERTA® (Methylphenidate Hydrochloride) as add-on Therapy in the Treatment of Adult Major Depressive Disorder. [Phase 3]
Summary
A Phase 3 study evaluating CONCERTA (methylphenidate hydrochloride) as add-on therapy for adults with major depressive disorder has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Janssen-Ortho Inc., Canada | Conditions: Depressive Disorder, Major | Phase 3 | Status: COMPLETED